1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Cacosmia in 4 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JG | 1 |
| Huh, E | 1 |
| Ju, IG | 1 |
| Kim, N | 1 |
| Yun, J | 1 |
| Oh, MS | 1 |
| Prediger, RD | 2 |
| Aguiar, AS | 1 |
| Rojas-Mayorquin, AE | 1 |
| Figueiredo, CP | 1 |
| Matheus, FC | 1 |
| Ginestet, L | 1 |
| Chevarin, C | 1 |
| Bel, ED | 1 |
| Mongeau, R | 1 |
| Hamon, M | 1 |
| Lanfumey, L | 1 |
| Raisman-Vozari, R | 1 |
| Castro, AA | 1 |
| Ghisoni, K | 1 |
| Latini, A | 1 |
| Quevedo, J | 1 |
| Tasca, CI | 1 |
| Miwa, T | 1 |
| Watanabe, A | 1 |
| Mitsumoto, Y | 1 |
| Furukawa, M | 1 |
| Fukushima, N | 1 |
| Moriizumi, T | 1 |
4 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Cacosmia
| Article | Year |
|---|---|
1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Choline O-Acetyltransferase; Disease Models, | 2018 |
Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Analysis of Variance; Anim | 2010 |
Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Age Factors; Animals; Anim | 2012 |
Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Corpus Striatum; Disease Models, | 2004 |